Endometriosis is a progressive, chronic condition where tissue that is similar to the lining of the uterus grows outside of the uterus on other organs. It can be painful and debilitating, but there are effective treatments that may relieve the symptoms of endometriosis.
In 2023, the Australian Institute of Health and Welfare (AIHW) reported that 1 in 7 (14%) people assigned female at birth in Australia and aged 50-55 are diagnosed with endometriosis by age 44–49. For women aged 29–34, 8.8% were estimated to have been diagnosed with endometriosis by age 26–31.
Endometriosis is often under-recognised, and diagnostic delay and affordability of ongoing care can have a substantial impact on quality of life on individuals, their family, partner, and carers.
The Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) has released the updated Australian Living-Evidence Guideline: Endometriosis, a clinical resource designed to improve consistency of care for people living with endometriosis, and adenomyosis.
A quick reference guide, with a summary flowchart has been developed by RANZCOG to support primary care providers. New resources are also available for the public too that can be accessed on the RANZCOG website.
These resources use the best available scientific evidence, with clinical expertise, and lived experience, to guide healthcare professionals in the detection, diagnosis and management of endometriosis, and adenomyosis.
“The living evidence guideline represents a major step forward in providing consistent, high-quality care for Australians living with confirmed and suspected endometriosis and adenomyosis. Considering up-to-date scientific evidence, expanded diagnostic options beyond surgery, and a truly interdisciplinary approach, we’re better positioned to deliver more timely, personalised, and effective care.”
– Professor Cindy Farquhar, Chair of the RANZCOG Endometriosis Guideline Development Group
For more information, visit the RANZCOG website.